Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Novanta Inc (NOVT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/13/2025: NOVT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Analysis of Past Performance
Type Stock | Historic Profit -23.05% | Avg. Invested days 42 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/13/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.64B USD | Price to earnings Ratio 72.65 | 1Y Target Price 161.11 |
Price to earnings Ratio 72.65 | 1Y Target Price 161.11 | ||
Volume (30-day avg) 246485 | Beta 1.34 | 52 Weeks Range 125.42 - 187.12 | Updated Date 04/1/2025 |
52 Weeks Range 125.42 - 187.12 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.76 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 6.75% | Operating Margin (TTM) 14.83% |
Management Effectiveness
Return on Assets (TTM) 6.05% | Return on Equity (TTM) 9.03% |
Valuation
Trailing PE 72.65 | Forward PE - | Enterprise Value 4956017738 | Price to Sales(TTM) 4.89 |
Enterprise Value 4956017738 | Price to Sales(TTM) 4.89 | ||
Enterprise Value to Revenue 5.22 | Enterprise Value to EBITDA 27.56 | Shares Outstanding 35960600 | Shares Floating 35595276 |
Shares Outstanding 35960600 | Shares Floating 35595276 | ||
Percent Insiders 0.9 | Percent Institutions 102.98 |
Analyst Ratings
Rating 3.75 | Target Price 164.78 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold 2 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Novanta Inc
Company Overview
History and Background
Novanta Inc. was founded in 2004. It evolved from General Scanning, focusing on precision motion, laser technology, and vision solutions. It has grown through strategic acquisitions and product innovation.
Core Business Areas
- Photonics: Designs, develops, manufactures, and markets photonics-based solutions, including laser beam steering components, laser sources, and laser machining systems.
- Vision: Provides embedded vision solutions, including cameras, frame grabbers, and image processing software, used in various industrial and medical applications.
- Precision Motion: Offers precision motion control components and subsystems, including encoders, motors, and drives, for applications requiring high accuracy and repeatability.
Leadership and Structure
The CEO is Matthijs Glastra. The organizational structure includes business segments and functional departments (e.g., finance, marketing, operations).
Top Products and Market Share
Key Offerings
- Synrad CO2 Lasers: CO2 lasers for cutting, marking, and engraving applications. Market share is estimated around 20-25% in certain segments. Competitors include Coherent, IPG Photonics, and Trumpf.
- Cambridge Technology Galvanometers: Galvanometers and scan heads for laser beam steering. Market share is estimated around 40-45% in certain segments. Competitors include Scanlab, Nutfield Technology.
- JADAK Barcode Scanners and RFID: Barcode scanners and RFID readers for healthcare and other industrial applications. Competitors include Zebra Technologies and Honeywell.
Market Dynamics
Industry Overview
The industry encompasses precision motion, photonics, and vision solutions, driven by automation, medical device advancements, and industrial manufacturing growth.
Positioning
Novanta is positioned as a technology partner offering specialized components and solutions. It has a competitive advantage in niche applications with high precision requirements.
Total Addressable Market (TAM)
The TAM is estimated at $10 billion. Novanta Inc is positioned to capture market share in segments such as medical and advanced industrial technologies.
Upturn SWOT Analysis
Strengths
- Strong brand reputation in specialized markets
- Diverse product portfolio
- High level of technical expertise
- Global presence
Weaknesses
- Dependence on specific industries
- Potential integration challenges from acquisitions
- Exposure to cyclical economic conditions
Opportunities
- Expanding into new geographic markets
- Developing innovative solutions for emerging applications
- Acquiring complementary businesses
- Increasing automation and robotics adoption
Threats
- Intense competition
- Technological obsolescence
- Economic downturns
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- IPGP
- COHR
- ROK
Competitive Landscape
Novanta has advantages in niche markets due to its specialized solutions. It faces competition from larger companies with broader product portfolios.
Major Acquisitions
Wintriss Engineering Corporation
- Year: 2020
- Acquisition Price (USD millions): 63
- Strategic Rationale: Strengthens Novanta's position in machine vision solutions.
Laser Quantum
- Year: 2017
- Acquisition Price (USD millions): 27.7
- Strategic Rationale: Enhances laser technology capabilities within photonics segment.
Growth Trajectory and Initiatives
Historical Growth: Novanta has experienced growth through organic expansion and strategic acquisitions.
Future Projections: Analysts project continued growth driven by expanding into new markets and product innovation.
Recent Initiatives: Recent initiatives include acquiring businesses to expand product offerings and investing in research and development.
Summary
Novanta Inc. shows a strong presence in specialized markets driven by its diverse product range and strategic acquisitions. Its technical expertise and global footprint aid in this, but integration challenges and industry cycles exist. Looking ahead, expanding geographically and innovating further will be vital amid competition and tech changes, ensuring strong market positioning.
Similar Companies
COHR
Coherent Inc
COHR
Coherent Inc
HON
Honeywell International Inc
HON
Honeywell International Inc
IPGP
IPG Photonics Corporation
IPGP
IPG Photonics Corporation
ROK
Rockwell Automation Inc
ROK
Rockwell Automation Inc
ZBRA
Zebra Technologies Corporation
ZBRA
Zebra Technologies Corporation
Sources and Disclaimers
Data Sources:
- Company filings, market reports, analyst estimates, industry publications.
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Novanta Inc
Exchange NASDAQ | Headquaters Bedford, MA, United States | ||
IPO Launch date 2016-01-04 | CEO & Chairman of the Board Mr. Matthijs Glastra | ||
Sector Technology | Industry Scientific & Technical Instruments | Full time employees 3000 | Website https://www.novanta.com |
Full time employees 3000 | Website https://www.novanta.com | ||
Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.